Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Fludarabine and Busulfan Plus Low Dose TBI Versus Cyclophosphamide Plus TBI in Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Equivalent Outcomes in a Recent, Large Canadian Multicenter Cohort

Craig Speziali, MD MSc, FRCPC, Andrew Daly, MD FRCPC, Mohamed Abuhaleeqa, MD, Janet Nitta, Yasser Abou Mourad, MD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Kristjan Paulson, MD FRCPC

Blood (2016) 128 (22): 663.

https://doi.org/10.1182/blood.V128.22.663.663

Published: 2016

Journal Articles

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

Junya Kanda, MD, David A. Rizzieri, MD, Cristina Gasparetto, MD, Gwynn D. Long, MD, John P. Chute, MD, Keith M. Sullivan, MD, Ashley Morris, PharmD, Clayton A. Smith, MD, FRCPC, Donna E. Hogge, MD, PhD, Janet Nitta, Kevin Song, MD, Donna Niedzwiecki, PhD, Nelson J. Chao, MD, Mitchell E. Horwitz, MD

Blood (2010) 116 (21): 3523.

https://doi.org/10.1182/blood.V116.21.3523.3523

Published: 2010

Journal Articles

The Use of Novel Agents In Patients with Multiple Myeloma Initially Treated with Allogeneic Stem Cell Transplantation Results In A Significant Prolongation of Post Relapse Survival.

Christopher P. Venner, MD, Heather Sutherland, MD, PhD, FRCPC, John Shepherd, MD, FRCPC, Yasser Abou Mourad, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MD, Thomas J. Nevill, MD, FRCPC, Janet Nitta, Maryse Power, MD, FRCPath, Cynthia Toze, MD, FRCPC, Clayton Smith, Kevin Song, MD

Blood (2010) 116 (21): 4580.

https://doi.org/10.1182/blood.V116.21.4580.4580

Published: 2010

Journal Articles

Exposure to Novel Agents Increases Post Relapse Survival in Patients with High Risk Myeloma Defined by Early Relapse (<12 months).

Christopher P. Venner, BSc, MD, Joseph M. Connors, MD, Heather J. Sutherland, MD, PhD, John D. Shepherd, MD, Linda Hamata, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, Thomas J. Nevill, MD, FRCPC, Janet Nitta, Maryse M Power, Cynthia L. Toze, MD, FRCP(C), Clayton Smith, MD, FRCPC, Kevin Song, MD

Blood (2009) 114 (22): 2872.

https://doi.org/10.1182/blood.V114.22.2872.2872

Published: 2009

Journal Articles

Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia.

Erica Peterson, M.Sc., M.D., Leslie Zypchen, MD, Janet Nitta, Jonathan Berkowitz, M.Sc., Ph.D., Lynda M Foltz, MD

Blood (2009) 114 (22): 2916.

https://doi.org/10.1182/blood.V114.22.2916.2916

Published: 2009

Journal Articles

Induction Therapy with High-Dose Dex Alone in Newly Diagnosed Myeloma Patients Produces a 57% Partial Response and Is Predictive of Progression Free Survival.

David A. Irvine, Michael J. Barnett, Ryan Brinkman, Donna L. Forrest, Donna E. Hogge, Julye Lavoie, Linda Lei, Stephen H. Nantel, Thomas J. Nevill, Janet Nitta, John Shepherd, Kevin Song, Cynthia Toze, Heather Sutherland

Blood (2006) 108 (11): 3098.

https://doi.org/10.1182/blood.V108.11.3098.3098

Published: 2006

Journal Articles

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).

Richard T. Doocey, MBChB, Matthew J. Greenwood, BMed, Dawn Warkentin, Kevin W. Song, MD, Alan Le, Janet Nitta, Thomas J. Nevill, MD, Michael J. Barnett, MD, Donna L. Forrest, MD, Donna E. Hogge, MD, PhD, Julye C. Lavoie, MD, Stephen H. Nantel, MD, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Cynthia L. Toze, MD, Clayton A. Smith, MD

Blood (2004) 104 (11): 5092.

https://doi.org/10.1182/blood.V104.11.5092.5092

Published: 2004

NARROW

Fludarabine and Busulfan Plus Low Dose TBI Versus Cyclophosphamide Plus TBI in Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Equivalent Outcomes in a Recent, Large Canadian Multicenter Cohort

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

The Use of Novel Agents In Patients with Multiple Myeloma Initially Treated with Allogeneic Stem Cell Transplantation Results In A Significant Prolongation of Post Relapse Survival.

Exposure to Novel Agents Increases Post Relapse Survival in Patients with High Risk Myeloma Defined by Early Relapse (<12 months).

Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia.

Induction Therapy with High-Dose Dex Alone in Newly Diagnosed Myeloma Patients Produces a 57% Partial Response and Is Predictive of Progression Free Survival.

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).

Email alerts

ASH Publications

American Society of Hematology

Fludarabine and Busulfan Plus Low Dose TBI Versus Cyclophosphamide Plus TBI in Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Equivalent Outcomes in a Recent, Large Canadian Multicenter Cohort

Adult Dual Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation (1350cGy) and Fludarabine Conditioning

The Use of Novel Agents In Patients with Multiple Myeloma Initially Treated with Allogeneic Stem Cell Transplantation Results In A Significant Prolongation of Post Relapse Survival.

Exposure to Novel Agents Increases Post Relapse Survival in Patients with High Risk Myeloma Defined by Early Relapse (<12 months).

Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia.

Induction Therapy with High-Dose Dex Alone in Newly Diagnosed Myeloma Patients Produces a 57% Partial Response and Is Predictive of Progression Free Survival.

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only